DiscoverNephU PodcastProteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials
Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

Update: 2024-08-19
Share

Description

The goal of this webinar is to discuss the evidence that supports proteinuria reduction as a surrogate marker in IgA Nephropathy clinical trials.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

NephU Community